325
Views
18
CrossRef citations to date
0
Altmetric
Review

Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications

, , , &

References

  • Diehl V, Sextro M, Franklin J, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin’s disease and lymphocyte-rich classical Hodgkin’s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin’s Disease. J Clin Oncol 1999;17(3):776-83
  • Saarinen S, Pukkala E, Vahteristo P, et al. High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 2013;31(7):938-43
  • Mason DY, Banks PM, Chan J, et al. Nodular lymphocyte predominance Hodgkin’s disease. A distinct clinicopathological entity. Am J Surg Pathol 1994;18(5):526-30
  • Poppema S, Delsol G, Pileri SA, Stein H. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. Editors WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC; Lyon: 2008. p. 323-5
  • Torlakovic E and Torlakovic G. B-cell markers in lymphocyte predominance Hodgkin disease. Arch Pathol Lab Med 2002;126(7):862-3
  • Carbone A, Gloghini A, Aldinucci D, et al. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. Br J Haematol 2002;117(2):366-72
  • Stein H and Bob R. Is Hodgkin lymphoma just another B-cell lymphoma? Curr Hematol Malig Rep 2009;4(3):125-8
  • Smith LB. Nodular lymphocyte predominant Hodgkin lymphoma: diagnostic pearls and pitfalls. Arch Pathol Lab Med 2010;134(10):1434-9
  • Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology 2011;58(5):803-5
  • Huppmann AR, Nicolae A, Slack GW, et al. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol 2014;38(3):316-24
  • Hartmann S, Eichenauer DA, Plutschow A, et al. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG). Br J Haematol 2014;167(2):238-42
  • Carbone A, Gloghini A, Cabras A, Elia G. The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol 2009;145(4):468-80
  • Hartmann S, Doring C, Jakobus C, et al. Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma-endpoints of a spectrum of one disease? PLoS One 2013;8(11):e78812
  • Carbone A, Ferlito A, Devaney KO, Rinaldo A. Ultrasound-guided core-needle biopsy: is it effective in the diagnosis of suspected lymphomas presenting in the head and neck? J Surg Oncol 2008;98(1):4-5
  • Carbone A and Gloghini A. CD75: a B-cell marker which should not be forgotten in lymphocyte predominant Hodgkin lymphoma. Am J Hematol 2014;89(4):449
  • Fan Z, Natkunam Y, Bair E, et al. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 2003;27(10):1346-5
  • Carbone A, Gloghini A. ‘Intrafollicular neoplasia’ of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease. Hum Pathol 2012;43(5):619-28
  • Carbone A and Gloghini A. Nodular lymphocyte predominant Hodgkin lymphoma may show a nodular pattern in which tumour cells do not invade the surrounding spaces. Br J Haematol 2013;163(4):537-8
  • Younes A, Carbone A, Johnson P, et al. Hodgkin’s lymphoma. In: De Vita VTJ, Lawrrence TS, Rosemberg SA, Editors) De Vita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014
  • Carbone A, Spina M, Gloghini A, et al. Nodular lymphocyte predominant Hodgkin lymphoma with non-invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome. Am J Hematol 2013;88(2):161-2
  • Xing KH, Connors JM, Lai A, et al. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood 2014;123(23):3567-73
  • Hartmann S, Eichenauer DA, Plutschow A, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 2013;122(26):4246; 52;quiz 4292
  • Advani RH, Hoppe RT. How I treat nodular lymphocyte predominant Hodgkin lymphoma. Blood 2013;122(26):4182-8
  • Mauz-Korholz C, Gorde-Grosjean S, Hasenclever D, et al. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 2007;110(1):179-85
  • Advani RH, Horning SJ, Hoppe RT, et al. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 2014;32(9):912-18
  • Eichenauer DA, Fuchs M, Pluetschow A, et al. Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood 2011;118(16):4363-5
  • Fanale MA, Lai C-M, MCLaughlin P, et al. Outcomes of nodular lymphocyte predominant Hodgkin’s lymphoma (NLPHL) patients treated with R-CHOP. ASH Annual Meeting Abstracts 2010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.